Symptoms – Page 12

Pleomorphic Carcinoma: Pathophysiology, Diagnosis, and Treatment Protocols

1. Introduction Pleomorphic carcinoma is an exceptionally rare, highly aggressive, and morphologically complex malignancy that represents a specific subset of sarcomatoid carcinomas, most frequently presenting within the pulmonary system. The defining feature of this diagnosis is its profound cellular heterogeneity. A pleomorphic carcinoma is essentially a hybrid neoplasm; it consists of a standard epithelial carcinoma … Read more

Large Cell Neuroendocrine Carcinoma: Diagnosis and Clinical Management

1. Introduction Large cell neuroendocrine carcinoma is a rare, high-grade, and biologically aggressive malignancy that typically arises within the pulmonary system. It represents a specific subset of non-small cell lung cancer that exhibits profound neuroendocrine differentiation. This diagnosis signifies a formidable clinical challenge, as the tumor cells possess the large physical size typical of non-small … Read more

Large Cell Carcinoma with Rhabdoid Phenotype: Clinical Guide and Treatment

1. Introduction Large cell carcinoma with rhabdoid phenotype represents an exceptionally rare, biologically aggressive, and histologically distinct variant of malignant epithelial neoplasia. While the rhabdoid morphology was initially identified in pediatric renal tumors, it is now recognized that this specific cellular phenotype can manifest in various adult carcinomas, most notably within the pulmonary system and … Read more

Glassy Cell Carcinoma: Symptoms, Diagnosis, and Clinical Care

1. Introduction Glassy cell carcinoma is a rare and particularly aggressive histological variant of cervical cancer. This condition represents a poorly differentiated form of adenosquamous carcinoma, indicating that the neoplastic cells exhibit features of both glandular and squamous epithelial lineages. The diagnosis of glassy cell carcinoma is clinically significant, as this specific tumor variant is … Read more

Giant Cell Carcinoma: Pathophysiology, Diagnosis, and Treatment

1. Introduction Giant cell carcinoma is a rare and aggressive histological variant of malignant epithelial neoplasia characterized by the prominent presence of exceptionally large, multinucleated neoplastic cells. This distinct diagnostic entity most frequently arises within the lung, though it can manifest in other organ systems such as the thyroid and pancreas. The diagnosis signals a … Read more

Giant Cell and Spindle Cell Carcinoma: Clinical Guide and Treatment

1. Introduction Giant cell and spindle cell carcinoma represents an exceedingly rare, aggressive, and histologically complex malignancy. While it can manifest in various organ systems, it is most frequently encountered and rigorously studied as a distinct subtype of metaplastic breast carcinoma. This unique diagnostic entity is characterized by a profound transformation of the malignant epithelial … Read more

Carcinoma, NOS: Diagnostic Challenges and Systemic Management

1. Introduction The diagnosis of Carcinoma, Not Otherwise Specified, represents one of the most complex and challenging scenarios in clinical oncology. This classification indicates that while the tumor has been definitively identified as a carcinoma—a malignant neoplasm originating from epithelial cells—the specific microscopic subtype or the precise anatomical organ of origin cannot be immediately ascertained … Read more

Carcinoma with Osteoclast-Like Giant Cells: Pathology and Treatment

1. Introduction Carcinoma with osteoclast-like giant cells represents an exceedingly rare and morphologically fascinating histological variant of invasive carcinoma. While this distinct entity can occasionally manifest in the pancreas or other organs, it is most frequently encountered and extensively studied within the context of breast oncology. The defining feature of this tumor is the dense … Read more

Malignant Epithelial Neoplasms: Pathophysiology and Clinical Care

1. Introduction Malignant epithelial neoplasms, universally classified in medical terminology as carcinomas, represent the most common category of cancer globally. These aggressive tumours originate from the epithelial cells that form the protective outer layers of the skin, line the internal cavities, and constitute the functional, secretory components of the body’s glandular organs. Unlike their benign … Read more

Carcinoma In Situ, NOS: Diagnosis, Characteristics, and Treatment

1. Introduction Carcinoma in situ represents a critical diagnostic category in modern oncology, denoting a pre-invasive stage of cellular malignancy. The designation “not otherwise specified” indicates that while the cells exhibit clear malignant features and remain confined to their original tissue layer, the exact histological subtype or specific cellular architecture cannot be definitively categorized into … Read more